文献速递乳腺技术与安全US

三维H扫描超声成像监测小鼠乳腺癌新辅助治疗早期反应

Three-Dimensional H-Scan Ultrasound Imaging of Early Breast Cancer Response to Neoadjuvant Therapy in a Murine Model.
PubMed 文献 · Invest Radiol · 2022-01-01

该临床前研究用40只荷乳腺癌小鼠,在凋亡诱导药物或生理盐水对照前后行三维H扫描超声成像,并与传统B扫描对比。结果显示H扫描对治疗后肿瘤变化更敏感,图像强度进行性下降且与癌细胞核尺寸线性相关,组织学验证支持其可早期检测乳腺癌治疗反应。

要点

  • 三维H扫描超声可无创检测乳腺癌凋亡诱导治疗的早期反应,较传统B扫描更敏感。
  • 治疗后可观察到H扫描图像强度进行性下降,且与癌细胞核尺寸变化相关。
  • 该技术有望为乳腺癌新辅助治疗的早期疗效评估提供影像学依据。

关键影像表现/征象

  • 治疗前基线时H扫描与B扫描结果无差异(P > 0.99)。
  • 治疗后H扫描图像强度进行性下降,第3天降幅达62.2%。
  • H扫描图像强度变化与癌细胞核尺寸呈显著线性相关(R2 > 0.51,P < 0.001)。

临床应用与阅片要点

  • 三维H扫描可评估整个肿瘤体积内声散射体相对尺寸的变化,较传统B扫描更敏感地反映治疗后早期改变。
  • 阅片时关注H扫描图像强度的进行性下降,其与癌细胞核尺寸变化相关,可作为早期治疗反应的潜在影像标志。

局限性

  • 研究为临床前小鼠模型,样本量40只,结果外推至人类乳腺癌需进一步验证。
  • 采用凋亡诱导药物模型,未涉及其他类型新辅助治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Three-dimensional (3D) H-scan is a new ultrasound (US) technique that images the relative size of acoustic scatterers. The goal of this research was to evaluate use of 3D H-scan US imaging for monitoring early breast cancer response to neoadjuvant therapy using a preclinical murine model of breast cancer.

MATERIALS AND METHODS: Preclinical studies were conducted using luciferase-positive breast cancer-bearing mice (n = 40). Anesthetized animals underwent US imaging at baseline before administration with an apoptosis-inducing drug or a saline control. Image data were acquired using a US scanner equipped with a volumetric transducer following either a shorter- or longer-term protocol. The later included bioluminescent imaging to quantify tumor cell viability. At termination, tumors were excised for ex vivo analysis.

RESULTS: In vivo results showed that 3D H-scan US imaging is considerably more sensitive to tumor changes after apoptosis-inducing drug therapy as compared with traditional B-scan US. Although there was no difference at baseline (P > 0.99), H-scan US results from treated tumors exhibited progressive decreases in image intensity (up to 62.2% by day 3) that had a significant linear correlation with cancer cell nuclear size (R2 > 0.51, P < 0.001). Results were validated by histological data and a secondary longitudinal study with survival as the primary end point.

DISCUSSION: Experimental results demonstrate that noninvasive 3D H-scan US imaging can detect an early breast tumor response to apoptosis-inducing drug therapy. Local in vivo H-scan US image intensity correlated with cancer cell nuclear size, which is one of the first observable changes of a cancer cell undergoing apoptosis and confirmed using histological techniques. Early imaging results seem to provide prognostic insight on longer-term tumor response. Overall, 3D H-scan US imaging is a promising technique that visualizes the entire tumor and detects breast cancer response at an early stage of therapy.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Tai H, Song J, Li J, et al. Three-Dimensional H-Scan Ultrasound Imaging of Early Breast Cancer Response to Neoadjuvant Therapy in a Murine Model. Invest Radiol. 2022. PMID: 34652291. doi:10.1097/RLI.0000000000000831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。